ZEUS System (Zio Watch) vs Zio XT ECG Monitoring System
AI Verdict
Choose ZEUS System (Zio Watch) if…
Choose the ZEUS System (Zio Watch) if your primary focus is comprehensive, long-term AFib burden characterization and you value the integration of both ECG and PPG data for broader cardiac insights. This system is also well-suited for practices looking to leverage a patient-facing app for digital symptom logging, educational content, and reminders to enhance patient engagement and adherence.
View ZEUS System (Zio Watch) →Choose Zio XT ECG Monitoring System if…
Choose the Zio XT ECG Monitoring System if you require a highly patient-friendly, discreet, and water-resistant solution for continuous single-lead ECG monitoring for up to 14 days. This tool is ideal for patients who prioritize comfort and minimal disruption to daily activities, ensuring high compliance for accurate arrhythmia detection and diagnosis through its wire-free design and expert review capabilities.
View Zio XT ECG Monitoring System →When choosing between iRhythm Technologies’ ZEUS System (Zio Watch) and Zio XT ECG Monitoring System, physicians should consider their primary monitoring needs and patient demographics. Both are FDA-cleared, AI-powered solutions for continuous cardiac monitoring, but they differ in their core technology and application.
The ZEUS System (Zio Watch) leverages a wearable biosensor that collects both ECG and PPG data, making it particularly adept at detecting and characterizing Atrial Fibrillation (AFib) burden. This system is ideal for physicians prioritizing comprehensive AFib analysis and those who value the integration of PPG for additional insights. Its ZioSuite portal and mobile app also offer robust tools for report interpretation and patient management, alongside a patient app for digital symptom logging.
In contrast, the Zio XT ECG Monitoring System utilizes a single-lead ECG biosensor, focusing on accurate arrhythmia detection and diagnosis through its proprietary AI algorithm and expert review. Its wire-free, water-resistant design enhances patient comfort and compliance, making it suitable for a broader range of patients, including those with active lifestyles. Physicians primarily needing reliable, long-term ECG monitoring for various arrhythmias, with a focus on patient convenience and high compliance, may find Zio XT to be the more practical choice.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ZEUS System (Zio Watch) | Zio XT ECG Monitoring System |
|---|---|---|
| Pricing | Contact vendor | Contact for pricing |
| Deployment | Cloud-based system with a wearable device | Cloud-based (AWS EC2 platform), no on-premise hardware required. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ZEUS System (Zio Watch)Tool A (ZEUS System / Zio Watch) offers a wrist-worn form factor and an integrated MyZio patient app for symptom logging, educational content, and reminders, providing a more holistic and potentially comfortable patient experience. While Tool B (Zio XT) emphasizes comfort with no wires and water resistance, some users have reported skin irritation from its adhesive patch, which can significantly impact long-term usability.
Clinical Value
Zio XT ECG Monitoring SystemTool B (Zio XT) is strongly cited for its clinical efficacy, demonstrating the highest diagnostic yield, lowest retesting rates, and fastest time to clinical diagnosis compared to other ambulatory ECG monitors. It also boasts a 99.9% clinician agreement rate. While Tool A (Zio Watch) provides accurate AFib burden estimates, it is often benchmarked against Zio XT, suggesting Zio XT as the established high-value reference.
Pricing & Value
Zio XT ECG Monitoring SystemTool B (Zio XT) offers greater transparency in its pricing, providing specific cost details for the UK (u00a3310 per patient) and proposed Medicare rates in the US (approximately $229-$260.35). In contrast, Tool A (ZEUS System / Zio Watch) only states 'contact vendor' for pricing, making it less transparent for potential buyers.
Enterprise Readiness
TieBoth tools are developed by iRhythm Technologies, are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAA). Both utilize cloud-based systems for deployment and provide portals/apps for physician report interpretation and patient management, indicating similar levels of enterprise-grade infrastructure and compliance.
Innovation
ZEUS System (Zio Watch)Tool A (ZEUS System / Zio Watch) represents a more novel approach with its wrist-worn biosensor capable of collecting both ECG and PPG data for continuous cardiac monitoring. This form factor, combined with its AI-powered algorithm for AFib detection and burden characterization, signifies a significant advancement in wearable cardiac diagnostics, fundamentally changing long-term patient monitoring.
Support & Docs
ZEUS System (Zio Watch)Tool A (ZEUS System / Zio Watch) enhances patient support through its MyZio patient app, which includes digital symptom logging, educational content, reminders, and instructional videos. While both tools offer comprehensive instructions for use and customer care, the interactive and educational features of the MyZio app provide a more robust and engaging support experience for patients compared to Tool B's physical logbook and button.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ZEUS System (Zio Watch) | Zio XT ECG Monitoring System |
|---|---|---|
| Device Type / Biosensor | Wearable biosensor (Zio Watch) for continuous ECG and PPG data collection | Wearable single-lead ECG biosensor (Zio biosensor) |
| Primary Detection Focus | Detects and characterizes Atrial Fibrillation (AFib) burden and other cardiac arrhythmias | Accurate arrhythmia detection and diagnosis |
| Monitoring Duration | Up to 14 days | Up to 14 days |
| AI Algorithm Description | AI-powered algorithm (ZEUS System) for advanced arrhythmia detection and analysis | Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis, utilizing FDA-cleared AI and expert review |
| Target Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology, Emergency Medicine, Internal Medicine |
| Patient Interaction Features | MyZiou00ae patient app for digital symptom logging, educational content, and reminders | Patient-activated button for symptomatic event logging |
Videos
Demos, reviews, and walkthroughs featuring ZEUS System (Zio Watch) and Zio XT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring ZEUS System (Zio Watch) or Zio XT ECG Monitoring System
Backers
Who funded each tool's parent company.